• Policy
• Will the number of generics decrease?
• by Lee, Tak-Sun Jul 13, 2023 05:35am

• Policy
• 2 Tylenol products stopped production will be decided in 2Q
• by Lee, Jeong-Hwan Jul 13, 2023 05:35am

• Policy
• Gov’s halts price cut discussions on generics
• by Lee, Jeong-Hwan Jul 10, 2023 05:21am

• Policy
• Taiwanese new drug receives reimb in only 1 yr since release
• by Lee, Tak-Sun Jul 7, 2023 05:43am

• Policy
• Evaluation different after Kymriah·Zolgensma benefits?
• by Lee, Tak-Sun Jul 7, 2023 05:43am

• Policy
• Pres. Yoon urges swift legislation for remote treatment
• by Kang, Shin-Kook Jul 6, 2023 05:39am

• Policy
• Roche Korea, "No decision has been made to resupply Madopar
• by Lee, Tak-Sun Jul 6, 2023 05:39am

• Policy
• Will AZ/Kolon succeed in challenging COPD combi benefit?
• by Lee, Tak-Sun Jul 5, 2023 05:45am

• Policy
• AZ Capivasertib, designated GIFT No. 8
• by Lee, Hye-Kyung Jul 5, 2023 05:45am

• Policy
• Mounjaro, a weight loss effect for DM pts, has been approved
• by Lee, Hye-Kyung Jul 3, 2023 05:47am